Please ensure Javascript is enabled for purposes of website accessibility

Why CVS Health Stock Gained 12% in April

By Demitri Kalogeropoulos - May 8, 2018 at 2:57PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares continued to swing in response to shifting fears about disruption in the drugstore retailing segment.

What happened

CVS Health (CVS 1.38%) beat the market last month, rising 12% compared to a roughly flat S&P 500, according to data provided by S&P Global Market Intelligence.

The rally erased some of the sharp decline shareholders had witnessed since the beginning of the year, but CVS Health continues to trail the market over the past one-year and three-year time frames.

^SPX Chart

^SPX data by YCharts.

So what

April's bounce came following reports that the drugstore chain might not face an immediate and intense threat from Amazon, Berkshire Hathaway, and JPMorgan Chase, which have announced a joint effort aimed at improving healthcare delivery. CVS Health shares had dropped following news of this strategic partnership, but recovered slightly last month as investors' fears eased.

Female pharmacist hands female customer prescribed drugs

Image source: Getty Images.

Now what

The retailer announced first-quarter results in early May that included solid sales gains in its retail segment due to a severe flu season. Its pharmacy business enjoyed healthy claim volume, too, even as pricing pressure remained a challenge.

However, thanks to healthy overall demand, CEO Larry Merlo and his team raised their 2018 revenue growth target to between 1.5% and 3%, up from the prior range of between 0.25% and 2%. Executives also believe adjusted earnings will rise by about 21%, due mainly to a lower effective tax rate.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CVS Health Corporation Stock Quote
CVS Health Corporation
CVS
$93.94 (1.38%) $1.28

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/05/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.